News - Mergers & Acquisitions, Novartis, Research

Filter

Proteon Thera gets new funding of $15 million, ahead of Novartis acquisition option

15-08-2011

US privately-held biopharmaceutical firm Proteon Therapeutics, the subject of a takeover option by Swiss…

BiotechnologyFinancialMergers & AcquisitionsNovartisPharmaceuticalProteon TherapeuticsResearch

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top